TY  - GEN
AU  - Evens,Andrew M
AU  - Sehn,Laurie H
AU  - Farinha,Pedro
AU  - Nelson,Beverly P
AU  - Raji,Adekunle
AU  - Lu,Yi
AU  - Brakman,Adam
AU  - Parimi,Vamsi
AU  - Winter,Jane N
AU  - Schumacker,Paul T
AU  - Gascoyne,Randy D
AU  - Gordon,Leo I
TI  - Hypoxia-inducible factor-1 {alpha} expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOP
SN  - 1527-7755
PY  - 2010///0323
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - metabolism
KW  - Cohort Studies
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Female
KW  - Follow-Up Studies
KW  - Gene Expression Profiling
KW  - Humans
KW  - Hypoxia-Inducible Factor 1, alpha Subunit
KW  - Immunoenzyme Techniques
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Prednisone
KW  - Prognosis
KW  - Retrospective Studies
KW  - Rituximab
KW  - Survival Rate
KW  - Tissue Array Analysis
KW  - Treatment Outcome
KW  - Vincristine
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2009.24.1893
ER  -